drugset / Trial / NCT03626727

Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

NCT03626727

Phase 0 Withdrawn Brigham and Women's Hospital
NaSingle-groupOpen-labelTreatment

Summary

The study evaluates whether the use of Sodium Oxybate (Xyrem®) in TBI patients will be effective in reducing symptoms of post traumatic narcolepsy and post traumatic hypersomnia.

Timeline

Start
2020-09
Primary completion
2020-09-01
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Oxybate Unknown 9 g Oral